Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 59651-009

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 59651-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (500 mg (60 Tablets Bottle))

Label for Ranolazine Extended-Release Tablets 500 mg, film-coated, 60 tablets per package. Distributed by Aurobindo Pharma USA, Inc., made in India. The label includes storage instructions, color additive information, and a barcode.*

FDA Label Image

Package Label-principal Display Panel (1000 mg (60 Tablets Bottle))

Label for Ranolazine 1000 mg extended-release film-coated tablets by Aurobindo Pharma Limited. The label indicates 60 tablets per bottle, includes storage instructions at 20°-25°C, and is marked Rx only. Distributed by Aurobindo Pharma USA, Inc., made in India. The label includes a barcode and usage notes.*

FDA Label Image

Chemical Structure (Ranolazine Str)

Chemical structure of Ranolazine, depicting the arrangement of its molecular components including aromatic rings, amide, and ether groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.